Compare BLDR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | MEDP |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.9B |
| IPO Year | 2005 | 2016 |
| Metric | BLDR | MEDP |
|---|---|---|
| Price | $82.04 | $495.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 13 |
| Target Price | $132.29 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 2.1M | 260.9K |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | 3.89 | ★ 15.28 |
| Revenue | ★ $15,190,638,000.00 | N/A |
| Revenue This Year | $1.00 | $13.19 |
| Revenue Next Year | $4.52 | $7.75 |
| P/E Ratio | ★ $20.34 | $32.61 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $76.50 | $250.05 |
| 52 Week High | $151.03 | $628.92 |
| Indicator | BLDR | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 60.69 |
| Support Level | $80.00 | $489.09 |
| Resistance Level | $130.47 | $501.30 |
| Average True Range (ATR) | 3.65 | 15.83 |
| MACD | 0.59 | 6.62 |
| Stochastic Oscillator | 36.64 | 89.19 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.